N Javeed, H Javeed, S Javeed, G Moussa, P Wong, F Rezai
{"title":"Refractory anaphylactoid shock potentiated by beta-blockers.","authors":"N Javeed, H Javeed, S Javeed, G Moussa, P Wong, F Rezai","doi":"10.1002/(SICI)1097-0304(199612)39:4<383::AID-CCD13>3.0.CO;2-E","DOIUrl":null,"url":null,"abstract":"<p><p>Allergic reactions, including anaphylactoid shock due to contrast material, are not uncommon. However, persistent anaphylactoid shock refractory to conventional therapy is rare. We present a case of refractory anaphylactoid shock during coronary angiography unresponsive to aggressive standard therapy in a patient on beta-blockers. Significant clinical improvement was noted upon administration of glucagon. Since beta-blockers are commonly used in patients with coronary artery disease, this potentially life-threatening complication has to be kept in mind with any procedure involving contrast media in patients on beta-blockers. Immediate access to glucagon by keeping it in the procedure room may be lifesaving in these situations.</p>","PeriodicalId":9664,"journal":{"name":"Catheterization and cardiovascular diagnosis","volume":"39 4","pages":"383-4"},"PeriodicalIF":0.0000,"publicationDate":"1996-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"52","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Catheterization and cardiovascular diagnosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/(SICI)1097-0304(199612)39:4<383::AID-CCD13>3.0.CO;2-E","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 52
Abstract
Allergic reactions, including anaphylactoid shock due to contrast material, are not uncommon. However, persistent anaphylactoid shock refractory to conventional therapy is rare. We present a case of refractory anaphylactoid shock during coronary angiography unresponsive to aggressive standard therapy in a patient on beta-blockers. Significant clinical improvement was noted upon administration of glucagon. Since beta-blockers are commonly used in patients with coronary artery disease, this potentially life-threatening complication has to be kept in mind with any procedure involving contrast media in patients on beta-blockers. Immediate access to glucagon by keeping it in the procedure room may be lifesaving in these situations.